ArticleFrontiers in oncology2023

Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule.

Maria Susanna Grimaudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.